Abstract:

Background: EAC helps clients overcome adherence hurdles and improve ART adherence. This study examines the effect of EAC on viral load suppression. Method: This quantitative study aims to determine the impacts of enhanced adherence counselling (EAC) on viral load in Defence Headquarters Medical Center, Abuja, Nigeria. The medical records of HIV clients on ART included in EAC were extracted from the hospital and analyzed to determine the impacts of EAC on viral loads suppression of clients in the program. Result: Almost half of the PLWHIV in EAC have been on ART for 6-10 years (47.6%), 42.9% for more than ten years, and 9.5% have been on ART for 1 – 5 years. 76.2% of respondents were on the 1st line of the ART regimen, while 23.8% were on the 2nd line. 97.6% of clients enrolled for EAC were at the WHO stage I HIV infection, and only one (2.4%) was in stage IV. 50% tested for viral load was due to viral blip, 28.6% due to unsuppressed viral load and 21.4% were tested to monitor their VL. Furthermore, of the 33 clients with viral load results, 14 (42.4%) had very low-level viremia (<50 copies/ml), 10 (30.3%) had low-level viremia (50–1000 copies/ml), but 9 (27.3%) still had high-level viremia (>1000 copies/ml). 42.9% enrolled for EAC because of pill burdens, 31.0% due to irregular dosing frequency, 19.0% because of pill social problems, and 2.1% were people lost to follow-up returned..

Keywords: Antiretroviral therapy, EAC, Viral load.

References:

[1] WHO. Adapting and Implementing New Recommendations on HIV Patient Monitoring. Geneva, Switzerland, 2017. 2017.

[2] Ministry of Health Uganda. Uganda Clinical Guidelines 2016. Retrieved on 21/6/2018. Minist Heal Uganda [Internet]. 2016;1–1142. Available from: http://health.go.ug/content/uganda-clinical-guidelines-2016.

[3] WHO. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Recommendations for a Public Health Approach. 2016;(2nd ed):1–429.

[4] MoH. National Training Curriculum for Roll Out of the Consolidated Guidelines for the Prevention and Treatment of Hiv and Aids in Uganda, 2020. 2020;142–170.

[5] Diress G, Dagne S, Alemnew B, Adane S, Addisu A. Viral Load Suppression after Enhanced Adherence Counseling and Its Predictors among High Viral Load HIV Seropositive People in North Wollo Zone Public Hospitals, Northeast Ethiopia, 2019: Retrospective Cohort Study. AIDS Res Treat. 2020;2020.

[6] Nasuuna E, Kigozi J, Babirye L, Muganzi A, Sewankambo NK, Nakanjako D. Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda. BMC Public Health. 2018;18(1).

[7] Usman S, Oluwaniyi O, Olubayo G, Akinmurele T, Agboola G, Abodunde F, et al. 90-90-90 Ambitious Targets: Achieving the Last 90 of the UNAIDS Targets in Western Nigeria. Int STD Res Rev. 2017;6(2):1–9.

[8] Fatunsi E, Ariyo A, Suraju A, Oguejiofor I, Tomori M, Owolagba FE, et al. The progress towards achieving the UNAIDS ambitious viral suppression target among adults living with HIV in South-Western Nigeria. 2020;2(1):8–12.

[9] Villa africa reality. Abuja - FCT | All About Nigeria’s Federal Capital City. 2021;1–1. Available from: https://www.villaafrika.com/fct-abuja-city-profile/.

[10] World Population. Review Abuja population 2021. 2021.

[11] Naiis. Nigeria Prevalence Rate - NACA Nigeria [Internet]. 2019 [cited 2021 Oct 18]. p. 1–1. Available from: https://naca.gov.ng/nigeria-prevalence-rate/.

[12] Hernán MA. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. Aids. 2010;24(1):123–37.

[13] Bock NN, Emerson RC, Reed JB, Nkambule R, Donnell DJ, Bicego GT, et al. Changing antiretroviral eligibility criteria: Impact on the number and proportion of adults requiring treatment in Swaziland. J Acquir Immune Defic Syndr [Internet]. 2016;71(3):338–44. Available from: https://doi.org/10.1097/QAI.0000000000000846%0APMID:26361174.

[14] Loutfy MR, Wu W, Letchumanan M, Bondy L, Antoniou T, Margolese S, et al. Systematic Review of HIV Transmission between Heterosexual Serodiscordant Couples where the HIV-Positive Partner Is Fully Suppressed on Antiretroviral Therapy. PLoS One [Internet]. 2013;8(2). Available from: https://doi.org/10.1371/journal.pone.%0A0055747 PMID: 23418455. Erratum in.

[15] Attia S, Egger M, Müller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis. Aids. 2009;23(11):1397–404.

[16] Jain V, Byonanebye DM, Amanyire G, Kwarisiima D, Black D, Kabami J, et al. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+T-cell counts above 350 cells/ml in rural Uganda. Aids [Internet]. 2014;28(15):2241–9. Available from: https://doi.org/10.1097/QAD.%0A0000000000000401 PMID: 25022596.

[17] Hall HI, Tang T, Westfall AO, Mugavero MJ. HIV care visits and time to viral suppression, 19 U.S. jurisdictions, and implications for treatment, prevention and the National HIV/AIDS Strategy. Plos One. 2013;8(12).

[18] World Health Organization. Guideline on When To Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva World Heal Organ. 2015;(September):1–76.

[19] Priscilla F., Mlay A. Factors associated with viral load suppression among HIV/AIDS adult patients on art medication. A case of Kisarawe district, pwani region. 2019.

[20] Wakooko P, Gavamukulya Y, Wandabwa JN. Viral load Suppression and Associated Factors among HIV Patients on Antiretroviral Treatment in Bulambuli District, Eastern Uganda : A Retrospective Cohort Study. 2020.

[21] Rangarajan S, Colby DJ, Giang LT, Bui DD, Hung Nguyen H, Tou PB, et al. Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam. J Virus Erad. 2016;2(2):94–101.

[22] Awolude OA, Olaniyi O, Moradeyo M, Abiolu J. Virologic Outcomes Following Enhanced Adherence Counselling among Treatment Experienced HIV Positive Patients at University College Hospital, Ibadan, Nigeria. 2021;10(1):53–65.

[23] Diress G, Dagne S, Alemnew B, Adane S, Addisu A. Viral Load Suppression after Enhanced Adherence Counseling and Its Predictors among High Viral Load
HIV Seropositive People in North Wollo Zone Public Hospitals, Northeast Ethiopia, 2019 : Retrospective Cohort Study. 2020;2020.

[24] Geretti AM, Smith C, Haberl A, Garcia-Diaz A, Nebbia G, Johnson M, et al. Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy. Antivir Ther. 2008;13(7):927–36.

[25] Peltzer K, Friend-Du Preez N, Ramlagan S, Anderson J. Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2010;10.

[26] NIAID. 10 Things to Know About HIV Suppression | NIH: National Institute of Allergy and Infectious Diseases [Internet]. 2020 [cited 2023 Jan 26]. p. 1–5. Available from: https://www.niaid.nih.gov/diseases-conditions/10-things-know-about-hiv-suppression.

[27] Brooks K, Diero L, DeLong A, Balamane M, Reitsma M, Kemboi E, et al. Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya. J Int AIDS Soc. 2016;19(1).

[28] Anne L, Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G. Factors Associated with Virological Failure and Suppression after Enhanced Adherence Counselling, in Children, Adolescents and Adults on Antiretroviral Therapy for HIV in Swaziland Authors Factors Associated with Virological Failure and Suppression afte. 2021;

[29] Talent Bvochora Id, Id SS, Takarinda KC, Bara H. Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe : Operational issues. 2019;444:1–13.